• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列遗传性皮肤卟啉病的临床特征:一项全国性调查。

Clinical features of genetic cutaneous porphyrias in Israel: A nationwide survey.

作者信息

Snast Igor, Kaftory Ran, Lapidoth Moshe, Mamet Rivka, Hodak Emmilia, Edel Yonatan, Levi Assi

机构信息

Division of Dermatology, Photodermatosis Service, Rabin Medical Center, Petah Tikva, Israel.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Photodermatol Photoimmunol Photomed. 2021 May;37(3):236-242. doi: 10.1111/phpp.12641. Epub 2020 Dec 20.

DOI:10.1111/phpp.12641
PMID:33306200
Abstract

BACKGROUND

There are three major types of genetic cutaneous porphyrias (GCP): erythropoietic protoporphyria (EPP), variegate porphyria (VP), and hereditary coproporphyria (HCP). Scarce data are available regarding their impact on patients' quality of life in the Mediterranean region.

PURPOSE

To describe the cutaneous features of GCP in Israel.

METHODS

An established nationwide cohort of patients with GCP diagnosed during 1988-2019 was surveyed by telephone for cutaneous features of GCP. Impact on quality of life was assessed using the Dermatology Life Quality Index.

RESULTS

Of the 95 patients with GCP, 71 (75%) completed the survey (21 HCP; 40 VP; 10 EPP). All EPP patients reported cutaneous symptoms compared with 58% of VP and 5% of HCP (P < .001). Mean age at symptom onset was 7 ± 6 years in EPP and 25 ± 15 years in VP (P < .001). Photosensitivity was the most common symptom in EPP (90%). In VP photosensitivity (52%), blistering (52%) and scarring (74%) were all common symptoms. In both VP and EPP, the dorsal hands/forearms were the most affected regions (≥96%), and in ≥ 78%, symptoms occurred on an almost daily basis. All EPP patients changed their lifestyle due to cutaneous symptoms vs 57% in VP. Major effect on quality of life was observed among EPP patients compared with a moderate effect in VP. No treatment was effective in EPP, while phototherapy and moisturizers were effective in 5 of 7 (71%) VP patients.

CONCLUSION

This study sheds light on the cutaneous features of the GCP, which have a substantial effect on patients' quality of life.

摘要

背景

遗传性皮肤卟啉病(GCP)主要有三种类型:红细胞生成性原卟啉病(EPP)、杂合性卟啉病(VP)和遗传性粪卟啉病(HCP)。关于它们对地中海地区患者生活质量的影响,可用数据稀少。

目的

描述以色列GCP的皮肤特征。

方法

通过电话调查了1988年至2019年期间确诊的全国性GCP患者队列的GCP皮肤特征。使用皮肤病生活质量指数评估对生活质量的影响。

结果

在95例GCP患者中,71例(75%)完成了调查(21例HCP;40例VP;10例EPP)。所有EPP患者均报告有皮肤症状,而VP患者为58%,HCP患者为5%(P<0.001)。EPP症状出现的平均年龄为7±6岁,VP为25±15岁(P<0.001)。光敏性是EPP最常见的症状(90%)。在VP中,光敏性(52%)、水疱形成(52%)和瘢痕形成(74%)都是常见症状。在VP和EPP中,双手背/前臂是受影响最严重的区域(≥96%),且≥78%的患者症状几乎每天都出现。所有EPP患者因皮肤症状改变了生活方式,而VP患者为57%。与VP患者的中度影响相比,EPP患者对生活质量有重大影响。EPP患者没有有效的治疗方法,而光疗和保湿剂对7例VP患者中的5例(71%)有效。

结论

本研究揭示了GCP的皮肤特征,其对患者的生活质量有重大影响。

相似文献

1
Clinical features of genetic cutaneous porphyrias in Israel: A nationwide survey.以色列遗传性皮肤卟啉病的临床特征:一项全国性调查。
Photodermatol Photoimmunol Photomed. 2021 May;37(3):236-242. doi: 10.1111/phpp.12641. Epub 2020 Dec 20.
2
Epidemiology of cutaneous porphyria in Israel: a nationwide cohort study.以色列皮肤卟啉症的流行病学:一项全国性队列研究。
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):184-187. doi: 10.1111/jdv.15769. Epub 2019 Jul 16.
3
The cutaneous porphyrias.皮肤型卟啉病
Semin Dermatol. 1990 Mar;9(1):63-9.
4
Greater disease burden of variegate porphyria than hereditary coproporphyria: An Israeli nationwide study of neurocutaneous porphyrias.混合型卟啉病比遗传性粪卟啉病的疾病负担更重:以色列全国性神经皮肤卟啉病研究。
Mol Genet Metab Rep. 2021 Jan 13;26:100707. doi: 10.1016/j.ymgmr.2021.100707. eCollection 2021 Mar.
5
Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.卟啉症遗传学的最新进展:遗传、外显率和分子异质性,包括新的修饰/致病基因。
Mol Genet Metab. 2019 Nov;128(3):320-331. doi: 10.1016/j.ymgme.2018.11.012. Epub 2018 Nov 30.
6
Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias.开发和验证用于卟啉症实验室诊断的诊断算法。
J Inherit Metab Dis. 2022 Nov;45(6):1151-1162. doi: 10.1002/jimd.12545. Epub 2022 Aug 26.
7
Acquired erythropoietic protoporphyria: A systematic review of the literature.获得性红细胞生成性原卟啉症:文献系统综述。
Photodermatol Photoimmunol Photomed. 2020 Jan;36(1):29-33. doi: 10.1111/phpp.12501. Epub 2019 Aug 21.
8
Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.人类卟啉症的鼠模型:对疾病发病机制的理解和新疗法的发展的贡献。
Mol Genet Metab. 2019 Nov;128(3):332-341. doi: 10.1016/j.ymgme.2019.01.007. Epub 2019 Jan 18.
9
Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.先天性红细胞生成性卟啉病和红细胞生成性原卟啉病:尿卟啉原 III 合酶和 20 个亚铁螯合酶新突变的鉴定。
Mol Genet Metab. 2019 Nov;128(3):358-362. doi: 10.1016/j.ymgme.2018.08.015. Epub 2018 Aug 31.
10
Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.英国的红细胞生成性原卟啉病:临床特征及对生活质量的影响。
Br J Dermatol. 2006 Sep;155(3):574-81. doi: 10.1111/j.1365-2133.2006.07472.x.